Epilepsy Trial, Recruiting (NCT05290610)

Epilepsy Trial, Recruiting NCT05290610 Sponsor: University of Minnesota Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT05290610 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older at the time of screening
You are willing and able to sign a consent form agreeing to take part in the study
You are willing to follow all study procedures and are available for the full length of the study
You are already scheduled to have electrodes placed inside your skull (intracranial EEG monitoring) as part of planning for epilepsy surgery through the University of Minnesota/MINCEP program

Who may not be able to join:

People who are pregnant (pregnancy must be ruled out before approval for the monitoring procedure)
People who are unable to fully understand the research due to its complexity, a cognitive impairment, or who are unable to make independent decisions about participation — including those in situations where their decision-making may be influenced by their relationship with the University of Minnesota or Fairview Health Services (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexander Herman, MD, UMN

Phone: 612-946-1424

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05290610

Sponsor: University of Minnesota

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 612-946-1424

More information: https://clinicaltrials.gov/study/NCT05290610

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older at the time of screening
You are willing and able to sign a consent form agreeing to take part in the study
You are willing to follow all study procedures and are available for the full length of the study
You are already scheduled to have electrodes placed inside your skull (intracranial EEG monitoring) as part of planning for epilepsy surgery through the University of Minnesota/MINCEP program

Who may not be able to join:

People who are pregnant (pregnancy must be ruled out before approval for the monitoring procedure)
People who are unable to fully understand the research due to its complexity, a cognitive impairment, or who are unable to make independent decisions about participation — including those in situations where their decision-making may be influenced by their relationship with the University of Minnesota or Fairview Health Services (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

1 June 2022

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The effect of prefrontal direct electrical brain stimulation on cognitive effort

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov